Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

This Gen Wellness vs Youth & Soul

This Gen Wellness
Graded #405

Lower grade

vs+4.700000000000003
Youth & Soul
Graded #291

Higher grade

The verdict

Youth & Soul takes it — 61.6/100 to 56.9/100.

Youth & Soul grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ten-vertical telehealth marketplace selling compounded GLP-1 tiers alongside HRT, ED, nootropics and peptides, running on the Bask Health platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueYouth & Soul +29
45
74
Dose & formulationYouth & Soul +24
40
64
Clinical oversightThis Gen Wellness +33
87
54
Labs & monitoringYouth & Soul +8
52
60
FulfillmentThis Gen Wellness +19
74
55
Contract termsYouth & Soul +4
45
49
This Gen Wellness · left barYouth & Soul · right bar

The numbers

MetricThis Gen WellnessYouth & Soul
WeighScore56.9/10061.6/100
GradeCC
Scorecard rank#405#291
SemaglutideNot disclosed$149/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
This Gen Wellness

Graded #405 · C

Strengths

  • Requires a synchronous live audio-video visit with a New York-licensed clinician — prescriptions are never issued from the intake form alone
  • Assessment and clinician review are free; you only pay if treatment is prescribed and you choose to proceed
  • Names its legal entity (ThisGen, LLC) and specifies New York governing law in its terms
  • No long-term contracts — plans can be paused or stopped
  • The same clinician follows your care, with ongoing secure messaging between visits

Where it loses points

  • Publishes no prices at all — 'We don't list flat prices on the website'; cost is disclosed only after a clinician reviews your assessment
  • Serves New York only — 'we currently operate exclusively for patients located in New York'
  • Dispensing pharmacies are not named, only described as 'licensed U.S. pharmacies'
  • Does not state whether its semaglutide and tirzepatide are compounded or brand-name
  • Does not bill insurance; verifying any reimbursement is the patient's responsibility
Youth & Soul

Graded #291 · C

Strengths

  • Three GLP-1 tiers priced openly, with the dose range and every included component listed per tier
  • Full refund advertised if you are not approved
  • Physician consultation, prescription and shipping stated as included in the plan price
  • Ten treatment verticals under one account, from GLP-1 to HRT, peptides and mental health

Where it loses points

  • Describes its compounded medications as FDA-Approved Compounds, which is false: compounded drugs are not FDA-approved
  • Presents scraped third-party comments as testimonials, several using Reddit usernames and some describing brand Wegovy or Mounjaro
  • Its own copy promises never to fabricate testimonials while displaying those scraped comments
  • Homepage trust counters render as 0K+ medical professionals, 0.0M+ patients and 0M+ successful orders
  • Labels its compounded tirzepatide a Mounjaro compound, conflating a compounded drug with the brand

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard